PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Menstrual Regulation”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 55 records · Page 3Linked to original sources

Retinoids and steroids regulate menstrual phase histological features in human endometrial organotypic cultures.

OBJECTIVE: To determine whether organotypic cultures of human endometrium can be manipulated with hormones to exhibit histological features resembling different menstrual cycle phases. DESIGN: Human menstrual cells were collected and cultured in monolayer and organotypic cultures. SETTING: Healthy volunteer in an academic research environment. PATIENT(S): An individual premenopausal woman. INTERVENTION(S): Endometrial cultures were grown in collagen gels for 4 weeks, and exposed to various steroid and retinoid treatments. MAIN OUTCOME MEASURE(S): Histological features and expression of cytokeratins, vimentin, and reticulin. RESULT(S): Cultures developed multiple glands and surface epithelium that exhibited positive cytokeratin and negative vimentin staining. Single stromal cells inside the collagen exhibited negative cytokeratin and positive vimentin staining. Networks of reticulin fibers produced by the cells were increased by estrogen, decreased by progesterone, and unaffected by retinoids. Contraction of the collagen gels was inhibited by retinoids that activated retinoic acid receptors (RARs), but not by a retinoid specific for retinoid X receptors (RXRs). The combination and timing of retinoid and steroid hormone treatments were demonstrated to induce tissue architecture and histological features that resembled either proliferative or secretory phases. CONCLUSION(S): Growth of menstrual cells in collagen can be manipulated with retinoids and steroids to resemble histological features of the proliferative and secretory phases.

Adult↗

Menstrual regulation by intramuscular injections of 16-phenoxy-tetranor PGE2 methyl sulfonylamide or vacuum aspiration. A randomized multicentre study. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation.

A multicentre trial was conducted to compare the efficacy and side-effects of an intramuscularly administered PGE2 analogue and vacuum aspiration in women with a delay of up to 21 days in the expected onset of menses. A total of 473 such women were randomly allocated to treatment with either 16-phenoxy-W-17, 18, 19, 20-tetranor PGE2 methyl sulfonylamide (three intramuscular injections of 0.5 mg at 3-h intervals) or vacuum aspiration, and the outcome of therapy assessed 1, 2 and 6-8 weeks later. Retrospective analysis of hCG levels indicated that 419 (88.6%) women had been pregnant at the time of treatment. With few exceptions, administration of the PGE2 analogue induced vaginal bleeding in both pregnant and non-pregnant women but the duration and subjectively perceived amount of bleeding were greater than after vacuum aspiration. Both treatments were equally effective. In pregnant women the overall frequency of complete abortion was 91% for prostaglandin treatment and 94% for vacuum aspirations. If non-pregnant women were included, the respective success rates (i.e. percentages of women not pregnant 2 weeks after treatment) were 92% and 95%. Gastrointestinal side-effects and lower abdominal pain requiring intramuscular analgesia were more common after prostaglandin therapy than following vacuum aspiration in both pregnant and non-pregnant women.

Abortifacient Agents↗